Used in pharmaceutical research as a key intermediate in the synthesis of potent DPP-4 inhibitors for the treatment of type 2 diabetes. It contributes to the development of antihyperglycemic agents by enhancing the stability and binding affinity of the final drug compound. Its structure supports improved metabolic resistance and target selectivity, making it valuable in optimizing oral glucose-lowering medications.